MRK vs TECH
By Alex · Tickerpine
Merck & Co., Inc. vs Bio-Techne Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | TECH |
|---|---|---|
| Price | $147.76 | $72.80 |
| Market cap | $364.26B | $11.44B |
| P/E ratio | 149.3 | 66.8 |
| ROE | 5.06% | 8.33% |
| Profit margin | 3.64% | 14.00% |
| Revenue growth | 4.70% | 4.60% |
| Dividend yield | 2.30% | 0.44% |
| Beta | 0.12 | 1.27 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs TECH in plain English
- MRK is the bigger company — about 31.9× the market cap of TECH.
- TECH is cheaper on earnings (P/E 66.8 vs 149.3).
- TECH earns a higher return on equity (8% vs 5%).
- MRK is growing revenue faster (5% vs 5%).
- MRK has the higher dividend yield (2.30% vs 0.44%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
TECH return calculator
See what $1,000 in Bio-Techne Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.